Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules

Author: Burstein Harold   Overmoyer Beth   Gelman Rebecca   Silverman Paula   Savoie Jennifer   Clarke Kathryn   Dumadag Leda   Younger Jerry   Ivy Percy   Winer Eric  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.25, Iss.2, 2007-04, pp. : 161-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content